Skip to main content

Publisher: Wiley-Blackwell

Volume 102, Supplement 176, 1 December 2000

Mutation of conserved aspartates affect maturation of presenilin 1 and presenilin 2 complexes
pp. 6-11(6)
Authors: Yu, G.; Chen, F.; Nishimura, M.; Steiner, H.; Tandon, A.; Kawarai, T.; Arawaka, S.; Supala, A.; Song, Y-Q.; Rogaeva, E.; Holmes, E.; Zhang, D.M.; Milman, P.; Fraser, P.; Haass, C.; St George-Hyslop, P.

Favourites:
ADD

A pharmacogenomic approach to Alzheimer's disease
pp. 12-19(8)
Authors: Cacabelos, R.; Alvarez, A.; Fenández-Novoa, L.; Lombardi, V.R.M.

Favourites:
ADD

Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate
pp. 20-26(7)
Authors: Chen, J.G.; Charles, H.C.; Barboriak, D.; Doraiswamy, P.M.

Favourites:
ADD

Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain
pp. 27-33(7)
Authors: Sihver, W.; Långström, B.; Nordberg, A.

Favourites:
ADD

Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types
pp. 34-41(8)
Authors: Martin-Ruiz, C.; Court, J.; Lee, M.; Piggott, M.; Johnson, M.; Ballard, C.; Kalaria, R.; Perry, R.; Perry, E.

Favourites:
ADD

Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis?
pp. 42-48(7)
Authors: Wevers, A.; Witter, B.; Moser, N.; Burghaus, L.; Banerjee, C.; Steinlein, O.K.; Schütz, U.; Vos, R.A.I.d.; Jansen Steur, E.N.H.; Lindstrom, J.; Schröder, H.

Favourites:
ADD

An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
pp. 49-52(4)
Authors: Sáez-Valero*, J.; Mok SS, S.; Small, D.H.

Favourites:
ADD

Acetylcholinesterase–amyloid-β-peptide interaction and Wnt signaling involvement in Aβ neurotoxicity
pp. 53-59(7)
Authors: Inestrosa, N.C.; Alvarez, A.; Godoy, J.; Reyes, A.; de Ferrari, G.V.

Favourites:
ADD

Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
pp. 60-67(8)
Authors: Lahiri, D.K.; Farlow, M.R.; Hintz, N.; Utsuki, T.; Greig, N.H.

Favourites:
ADD

Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR
pp. 68-73(6)
Authors: Samochocki, M.; Zerlin, M.; Jostock, R.; Groot Kormelink, P.J.; Luyten, W.H.M.L.; Albuquerque, E.X.; Maelicke, A.

Favourites:
ADD

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics
pp. 74-84(11)
Authors: Greig, N.H.; de Micheli, E.; Holloway, H.W.; Yu Q.-S.; Utsuki, T.; Perry, T.A.; Ingram, D.K.; Deutsch, J.; Lahiri, D.; Soncrant, T.T.

Favourites:
ADD

Immediate causes of death of demented and non-demented elderly
pp. 96-99(4)
Authors: Kammoun, S.; Gold, G.; Bouras, C.; Giannakopoulos, P.; McGee, W.; Herrmann, F.; Michel, J-P.

Favourites:
ADD

Immediate causes of death of demented and non-demented elderly
pp. 96-99(4)
Authors: Kammoun, S.; Gold, G.; Bouras, C.; Giannakopoulos, P.; McGee, W.; Herrmann, F.; Michel, J-P.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more